[1] Huang PK, Hsieh LC, Leu YS.Thyroglossal duct cyst papillary carcinoma with airway compromise[J]. Ear Nose Throat J, 2021:1455613211022077. [2] Nuzzo F, Beshlawi I, Wali Y, et al.High incidence of intracranial bleeding in factor V-deficient patients with homozygous F5 splicing mutations[J]. Br J Haematol, 2017, 179(1): 163-166. [3] Thalji N, Camire RM.Parahemophilia: new insights into factor V deficiency[J]. Semin Thromb Hemost, 2013, 39(6): 607-612. [4] Nakashima K, Hari Y, Takagi H, et al.A case of mitral valve repair complicated by acquired factor V deficiency[J]. Gen Thorac Cardiovasc Surg, 2021, 69(5): 874-876. [5] Yanagiya R, Kanouchi K, Toubai T, et al.Plasma exchange as an initial treatment for severe bleeding induced by acquired factor V deficiency: a case report and mini literature review[J]. Acta Haematol, 2021, 144(1): 82-87. [6] Wu AH, Manje Gowda A, Peng S, et al.Successful management of life-threatening pelvic hemorrhage from acquired factor V deficiency with immunosuppressive therapy[J]. Cureus, 2020, 12(8): e9972. [7] Oomen KP, Modi VK, Maddalozzo J.Thyroglossal duct cyst and ectopic thyroid: surgical management[J]. Otolaryngol Clin North Am, 2015, 48(1): 15-27. [8] Dahlbäck B.Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders[J]. Int J Lab Hematol, 2016, 38(Suppl 1): 4-11. [9] Lippi G, Favaloro EJ, Montagnana M, et al.Inherited and acquired factor V deficiency[J]. Blood Coagul Fibrinolysis, 2011, 22(3): 160-166. [10] Tabibian S, Shiravand Y, Shams M, et al.A comprehensive overview of coagulation factor V and congenital factor V deficiency[J]. Semin Thromb Hemost, 2019, 45(5): 523-543. [11] Tabibian S, Dorgalaleh A, Camire RM.Congenital factor V defificiency. Congenital bleeding disorders[M]. New York, NY: Springer; 2018: 201-218. [12] D rzymalski DM, Elsayes AH, Ward KR, et al. Platelet transfusion as treatment for factor V deficiency in the parturient: a case report[J]. Transfusion, 2019, 59(7): 2234-2237. [13] Bulato C, Novembrino C, Anzoletti MB, et al."In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate[J]. Haemophilia, 2018, 24(4): 648-656. |